This review will explore the four major pillars required for design and development of an saRNA vaccine: antigen design, vector design, non-viral delivery systems, and manufacturing (both saRNA and lipid nanoparticles (LNP)). In will report on the major innovations, preclinical and clinical data reported in the last five years and will discuss future prospects.
We use cookies on our website to ensure you get the best experience. Read more about our cookies here.
RSS feed for
Preprints: The Multidisciplinary Preprint Platform
Paste the URL in your RSS reader:
https://www.preprints.org/rss
If you want to subscribe our website in subject-wide, you could find the URL by choosing in the following: